STC:DBD's PB Ratio is ranked worse than 65.84% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs STC:DBD: 2.77
During the past 12 months, Binh Dinh Pharmaceutical And Medical Equipment JSC's average Book Value Per Share Growth Rate was 3.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 11.90% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Binh Dinh Pharmaceutical And Medical Equipment JSC was 13.40% per year. The lowest was 8.20% per year. And the median was 13.20% per year.
Back to Basics: PB Ratio
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Binh Dinh Pharmaceutical And Medical Equipment JSC PB Ratio Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC PB Ratio Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC PB Ratio vs Drug Manufacturers Industry
Binh Dinh Pharmaceutical And Medical Equipment JSC PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a PB Ratio of 2.77 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is near median its historical median of 2.66. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's PB Ratio has ranged from 2.02 to 3.49. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #607 out of 922 companies in the Drug Manufacturers industry, placing it in the top 65.8%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's PB Ratio too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current PB Ratio of 2.77 is near median its 10-year median of 2.66. Over the past 10 years, this metric has ranged from a low of 2.02 to a high of 3.49. The Drug Manufacturers industry median PB Ratio is 1.83. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 2.77 is 51.8% above this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #607 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #607 out of 922 companies for PB Ratio. This places Binh Dinh Pharmaceutical And Medical Equipment JSC in the lower half of its industry. The industry median PB Ratio is 1.83. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 2.77 is 51.8% above this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own PB Ratio has ranged from 2.02 to 3.49 over the past decade. While the company's 10-year median is 2.66 vs. the industry median of 1.83, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current PB Ratio of 2.77 is 51.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current PB Ratio is 2.77, which is near median its own 10-year median of 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,212.47, compared to a current price of ₫53,200.00 — trading 1.9% above its estimated fair value. The current PB Ratio is 2.77, which is near median its 10-year median of 2.66 and 51.8% above the Drug Manufacturers industry median of 1.83. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current PB Ratio is 2.77 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be overvalued.
The current stock price of ₫53,200.00 is trading 1.9% above its estimated GF Value™ of ₫52,212.47.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
PB Ratio: 2.77 (near median its 10-year median of 2.66)
GF Value™: ₫52,212.47 vs. price of ₫53,200.00 (1.9% above fair value)
Industry Position: 51.8% above the Drug Manufacturers median (#607 of 922)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
